跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZIMED PF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZIMED PF
Authorized
STANDARD
ZIMED PF
aequus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fd9d30d9ca0dcfe3
Company
aequus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
fd9d30d9ca0dcfe3
Drug Approval Canada Name
ZIMED PF
Product Name
ZIMED PF
Status
Marketed
Status Date
2023-09-12
Original Market Date
2023-09-12
Din
02533464
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.28
Atc Original
S01EE03 BIMATOPROST
Atc Name
s 01 ee 03
Aig Number
0147303001
Company Name
aequus pharmaceuticals inc.
Company Address
200 Granville Street, Suite 2820, Vancouver, British Columbia, Canada, V6C 1S4
Active Ingredients
BIMATOPROST
0.03 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fd9d30d9ca0dcfe3
Type
Standard
Back to Health Canada Approvals